In Part Two, putting theory into practice is addressed.

The reduction in Bayer's workforce under turnaround chief executive Bill Anderson has reached around 12,000 – a fall of ...

Researchers at the University of Arizona recently studied a non-invasive technique that uses sound waves to stimulate ...

The joint information sharing agreement between the medicines regulatory authority and reimbursement agency was first ...

Novo Nordisk's already depressed share price has fallen again this morning, despite reporting an 18% increase in sales in the ...

A jury in the US has found that tech giant Meta illegally compromised the privacy of a US woman who shared her data with a ...

US Health and Human Services (HHS) Secretary Robert F Kennedy Jr has said he will cut $500 million in funding for mRNA ...

At HLTH Europe 2025 in Amsterdam, pharmaphorum Deep Dive editor Eloise McLennan sat down with Eugene Borukhovich (CEO, YourCoach Health), David Klein (CEO, Click Therapeutics), and Malin Johansson ...

The UK has started a 'world-first' gonorrhoea vaccination programme that is designed to prevent thousands of cases and save ...

Pharma 4.0 is no longer a future ambition; it’s the baseline. The ability to operate with real-time data, integrated systems, ...

AMR demands sustained commitment beyond conventional market incentives. It requires founders with deep personal conviction ...

Vertex already has FDA approval for NaV1.8 inhibitor Journavx (suzetrigine) in acute pain, with late-stage trials on the go ...